Prothrombin concentration in the cerebrospinal fluid is not altered in Alzheimer's disease

Neurochemical Research

Volumn 24, Issue 12, 1999, Pages 1531-1534

  Lewczuk, P ^a   Wiltfang, J ^a   Lange, M ^c   Jahn, H ^c   Reiber, H ^a   Ehrenreich, H ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^c Max Planck Inst for Exp Medicine ^*

Author keywords

Alzheimer; Blood CSF barrier; Cerebrospinal fluid; ELISA; Neurological disorders; Prothrombin

Indexed keywords

PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN FUNCTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; GUILLAIN BARRE SYNDROME; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

EID: 0032727703     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021147914843     Document Type: Article

References (16)

1. Goldsack, N. R., Chambers, R. C., Dabbagh, K., and Laurent, G. J. 1998. Thrombin. Int. J. Biochem. Cell Biol. 30:641-646.
2. Fenton, J. W., 2nd, Ofosu, F. A., Brezniak, D. V., and Hassouna, H. I. 1998. Thrombin and antithrombotics. Semin. Thromb. Hemost. 24:87-91.
3. Turgeon, V. L., and Houenou, L. J. 1997. The role of thrombin-like (serine) proteases in the development, plasticity and pathology of the nervous system. Brain Res. Brain Res. Rev. 25:85-95.
4. Sekiya, F., Usui, H., Inoue, K., Fukudome, K., and Morita, T. 1994. Activation of prothrombin by a novel membrane-associated protease. An alternative pathway for thrombin generation independent of the coagulation cascade. J. Biol. Chem. 269: 32441-32445.
5. Akiyama, H., Ikeda, K., Kondo, H., and McGeer, P. L. 1992. Thrombin accumulation in brains of patients with Alzheimer's disease. Neurosci. Lett. 146:152-154.
6. Wang, X., An, S., and Wu, J. M. 1996. Specific processing of native and phosphorylated tau protein by proteases. Biochem. Biophys. Res. Commun. 219:591-597.
7. Haas, C., Aldudo, J., Cazorla, P., Bullido, M. J., de Miguel, C., Vazquez, J., and Valdivieso, F. 1997. Proteolysis of Alzheimer's disease beta-amyloid precursor protein by factor Xa. Biochim. Biophys. Acta. 1343:85-94.
8. Smirnova, I. V., Salazar, A., Arnold, P. M., Glatt, S., Handler, M., and Festoff, B. W. 1997. Thrombin and its precursor in human cerebrospinal fluid. Thromb. Haemost. 78:1473-1479.
9. Lewczuk, P., Reiber, H., and Ehrenreich, H. 1998. Prothrombin in normal human cerebrospinal fluid originates from the blood. Neurochem. Res. 23:1027-1030.
10. Nemetz, P. N., Leibson, C., Naessens, J. M., Beard, M., Kokmen, E., Annegers, J. F., and Kurland, L. T. 1999. Traumatic brain injury and time to onset of Alzheimer's disease: a population-based study. Am. J. Epidemiol. 149:32-40.
11. Wagner, S. L., Geddes, J. W., Cotman, C. W., Lau, A. L., Gurwitz, D., Isackson, P. J., and Cunningham, D. D. 1989. Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease. Proc. Natl. Acad. Sci. USA 86:8284-8288.
12. Reiber, H. 1995. Die diagnostische Bedeutung neuroimmunologischer Reaktionsmuster im Liquor cerebrospinalis. Lab. Med. 19:444-462.
13. American Psychiatric Association (APA) 1994. Diagnostic and statistical manual of mental disorders. Washington DC.
14. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E. M. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944.
15. Folstein, M. F., Folstein, S. E., and McHugh, P. R. 1975. "Minimental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:189-198.
16. Reiber, H. 1994. Flow rate of cerebrospinal fluid (CSF) - a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J. Neurol. Sci. 122:189-203.